Women’s health medical device company CerviLenz has raised an additional $2 million in equity, according to a recently filed regulatory document.The funding would seem to bring the Cleveland-area device maker’s series A round of investment to $10.35 million. Company officials in October pegged the series A at $8.35 million, but declined comment on the latest [...]

The U.S. Food and Drug Administration is soon expected to decide whether to approve a progesterone vaginal gel that could reduce preterm birth in women.Cleveland-area CerviLenz, which makes a device to measure the length of a woman’s cervix, is closely watching the FDA’s decision. Approval of the drug, Prochieve 8%, could speed adoption of CerviLenz’s [...]

This post is sponsored by Cervilenz Inc.12.9 million babies are born too soon every year around the world, and 1 million of those babies die. The United States has the second-highest rate of prematurity in the world. Here, 1 of 8 babies is born prematurely, and these early deliveries are the leading cause of infant [...]

This post is sponsored by Cervilenz Inc.November is a time for thanks. Every day, I am thankful for my husband, Jim, and our three healthy children– Emmett, Riley, and Allie. But, this time of year is a mixed blessing for me.November is Prematurity Awareness Month. Every minute of every day, a baby is born prematurely. [...]

Women’s health medical device company Cervilenz has increased its series A round of investment to $8.35 million, thanks to a recent tranche of funding from existing investors.Cleveland-area Cervilenz plans to use the funding to continue commercialization of its device, which provides a means of accurately and inexpensively measuring a pregnant woman’s cervix. A short cervix [...]

MedCity News’ Brandon Glenn discusses the opportunities a new progesterone drug could have for Ohio medical device company CerviLenz on this week’s edition of Health Journal on ONN.CerviLenz’s device provides a means of accurately and inexpensively measuring a pregnant woman’s cervix. The new drug, Prochieve 8%, is a gel that was associated in a [...]

Pending regulatory approval of a progesterone drug could open up a new, lucrative market in helping prevent premature births for medical device maker CerviLenz.The drug, Prochieve 8%, is a gel that was associated in a Phase 3 clinical trial with a 45 percent reduction in preterm births in pregnant women with a short cervix, and [...]

Medical device startup CerviLenz Inc. has appointed its first chief financial/operating officer: Federica “Freddi” O’Brien, a certified public accountant who spent the last decade working with bioscience companies.“I have 30 years of experience working with middle-market, development-stage companies, as well as big pharma companies,” O’Brien said. “I had been tracking CerviLenz since I heard about [...]

MedCity News President Chris Seper appeared on air of content partner WKYC-TV, discussing three Cleveland-area medical device companies: AxioMed Spine, CerviLenz and Neuros Medical.

CerviLenz is a simple, low-tech medical device that prompts a “why didn’t I think of that?” response from many obstetricians.Yet the device that quickly, accurately and inexpensively measures a pregnant woman’s cervix could help answer the $26 billion-a-year problem of preterm births in the United States.And CerviLenz, the Chagrin Falls, Ohio, company commercializing the device, [...]